AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ASML Holding N.V.

Quarterly Report Jan 24, 2024

3813_iss_2024-01-24_6c6c5f22-4586-4e48-8f4d-be81ece44039.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

ASML - Summary US GAAP Consolidated Statements of Operations

Three months ended, Twelve months ended,
Dec 31, Dec 31, Dec 31, Dec 31,
(unaudited, in millions €, except per share data) 2022 2023 2022 2023
Net system sales 4,747.9 5,682.5 15,430.3 21,938.6
Net service and field option sales 1,682.3 1,554.5 5,743.1 5,619.9
Total net sales 6,430.2 7,237.0 21,173.4 27,558.5
Total cost of sales (3,119.3) (3,519.7) (10,473.3) (13,422.4)
Gross profit 3,310.9 3,717.3 10,700.1 14,136.1
Research and development costs (906.3) (1,041.3) (3,253.5) (3,980.6)
Selling, general and administrative costs (280.4) (284.1) (945.9) (1,113.2)
Income from operations 2,124.2 2,391.9 6,500.7 9,042.3
Interest and other, net (3.1) 5.2 (44.6) 41.2
Income before income taxes 2,121.1 2,397.1 6,456.1 9,083.5
Income tax expense (357.3) (385.6) (969.9) (1,435.8)
Income after income taxes 1,763.8 2,011.5 5,486.2 7,647.7
Profit related to equity method investments 52.7 36.6 138.0 191.3
Net income 1,816.5 2,048.1 5,624.2 7,839.0
Basic net income per ordinary share 4.60 5.21 14.14 19.91
Diluted net income per ordinary share 4.60 5.20 14.13 19.89
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 394.9 393.4 397.7 393.8
Diluted 395.2 393.8 398.1 394.1

ASML - Ratios and Other Data

Three months ended, Twelve months ended,
Dec 31, Dec 31, Dec 31, Dec 31,
(unaudited, in millions €, except otherwise indicated) 2022 2023 2022 2023
Gross profit as a percentage of net sales 51.5 % 51.4 % 50.5 % 51.3 %
Income from operations as a percentage of net sales 33.0 % 33.1 % 30.7 % 32.8 %
Net income as a percentage of net sales 28.2 % 28.3 % 26.6 % 28.4 %
Income taxes as a percentage of income before income taxes 16.8 % 16.1 % 15.0 % 15.8 %
Shareholders' equity as a percentage of total assets 24.3 % 33.7 % 24.3 % 33.7 %
Sales of lithography systems (in units) 1 106 124 345 449
Value of booked systems 6,316
2
9,186
2
30,674
3
20,040
3
Number of payroll employees in FTEs 36,112 40,310 36,112 40,310
Number of temporary employees in FTEs 2,974 2,107 2,974 2,107
    1. Lithography systems do not include metrology and inspection systems.
    1. Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.
    1. The sum of quarterly net bookings over the full year.

ASML - Summary US GAAP Consolidated Balance Sheets

Dec 31, Dec 31,
(unaudited, in millions €) 2022 2023
ASSETS
Cash and cash equivalents 7,268.3 7,004.7
Short-term investments 107.7 5.4
Accounts receivable, net 5,323.8 4,334.1
Finance receivables, net 1,356.7 1,379.2
Current tax assets 33.4 1,001.2
Contract assets 131.9 240.1
Inventories, net 7,199.7 8,850.7
Other assets 1,643.4 1,578.5
Total current assets 23,064.9 24,393.9
Finance receivables, net 60.6
Deferred tax assets 1,672.8 1,872.3
Loan receivable 364.4 929.2
Other assets 739.8 651.8
Equity method investments 923.6 919.6
Goodwill 4,555.6 4,588.6
Other intangible assets, net 842.4 741.7
Property, plant and equipment, net 3,944.2 5,493.2
Right-of-use assets 192.7 306.6
Total non-current assets 13,235.5 15,563.6
Total assets 36,300.4 39,957.5
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities 17,983.6 16,274.8
Total current liabilities 17,983.6 16,274.8
Long-term debt 3,514.2 4,631.5
Deferred and other tax liabilities 267.0 372.2
Contract liabilities 5,269.9 4,825.5
Accrued and other liabilities 454.9 401.2
Total non-current liabilities 9,506.0 10,230.4
Total liabilities 27,489.6 26,505.2
Total shareholders' equity 8,810.8 13,452.3
Total liabilities and shareholders' equity 36,300.4 39,957.5

ASML - Summary US GAAP Consolidated Statements of Cash Flows

Three months ended, Twelve months ended,
Dec 31, Dec 31, Dec 31, Dec 31,
(unaudited, in millions €) 2022 2023 2022 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,816.5 2,048.1 5,624.2 7,839.0
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 183.2 212.1 583.6 739.8
Impairment and loss (gain) on disposal 13.7 10.0 39.3 37.5
Share-based compensation expense 21.0 41.6 68.9 134.8
Inventory reserves 71.3 210.7 278.5 485.3
Deferred tax expense (benefit) (89.0) (48.9) (564.2) (133.6)
Equity method investments 120.8 175.7 15.3 4.2
Changes in assets and liabilities 3,213.0 547.7 2,441.2 (3,663.6)
Net cash provided by (used in) operating activities 5,350.5 3,197.0 8,486.8 5,443.4
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (453.6) (584.0) (1,281.8) (2,155.6)
Purchase of intangible assets (12.3) (18.3) (37.5) (40.6)
Purchase of short-term investments (4.2) (1.0) (334.3) (23.6)
Maturity of short-term investments 106.1 0.9 864.7 125.6
Loans issued and other investments (8.5) (240.0) (561.5)
Acquisition of subsidiaries (net of cash acquired) (6.0) (33.6)
Net cash provided by (used in) investing activities (364.0) (616.9) (1,028.9) (2,689.3)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (541.1) (570.8) (2,559.8) (2,348.3)
Purchase of treasury shares (335.0) (4,639.7) (1,000.0)
Net proceeds from issuance of shares 18.9 25.9 81.8 99.4
Net proceeds from issuance of notes, net of issuance costs 495.6 997.8
Repayment of debt and finance lease obligations (0.8) (0.2) (516.2) (752.8)
Net cash provided by (used in) financing activities (858.0) (545.1) (7,138.3) (3,003.9)
Net cash flows 4,128.5 2,035.0 319.6 (249.8)
Effect of changes in exchange rates on cash (13.0) (5.8) (3.1) (13.8)
Net increase (decrease) in cash and cash equivalents 4,115.5 2,029.2 316.5 (263.6)
Cash and cash equivalents at beginning of the period 3,152.8 4,975.5 6,951.8 7,268.3
Cash and cash equivalents at end of the period 7,268.3 7,004.7 7,268.3 7,004.7

ASML - Quarterly Summary US GAAP Consolidated Statements of Operations

Three months ended,
Dec 31, Apr 2, July 2, Oct 1, Dec 31,
(unaudited, in millions €, except per share data) 2022 2023 2023 2023 2023
Net system sales 4,747.9 5,341.8 5,606.1 5,308.2 5,682.5
Net service and field option sales 1,682.3 1,404.4 1,296.2 1,364.8 1,554.5
Total net sales 6,430.2 6,746.2 6,902.3 6,673.0 7,237.0
Total cost of sales (3,119.3) (3,333.0) (3,358.3) (3,211.4) (3,519.7)
Gross profit 3,310.9 3,413.2 3,544.0 3,461.6 3,717.3
Research and development costs (906.3) (947.9) (999.9) (991.4) (1,041.3)
Selling, general and administrative costs (280.4) (260.3) (281.1) (287.8) (284.1)
Income from operations 2,124.2 2,205.0 2,263.0 2,182.4 2,391.9
Interest and other, net (3.1) 12.2 16.7 7.1 5.2
Income before income taxes 2,121.1 2,217.2 2,279.7 2,189.5 2,397.1
Benefit from (provision for) income taxes (357.3) (302.6) (403.9) (343.7) (385.6)
Income after income taxes 1,763.8 1,914.6 1,875.8 1,845.8 2,011.5
Profit related to equity method investments 52.7 41.2 65.9 47.6 36.6
Net income 1,816.5 1,955.8 1,941.7 1,893.4 2,048.1
Basic net income per ordinary share 4.60 4.96 4.93 4.81 5.21
Diluted net income per ordinary share 4.60 4.95 4.93 4.81 5.20
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 394.9 394.5 393.8 393.4 393.4
Diluted 395.2 394.8 394.0 393.7 393.8

ASML - Quarterly Summary Ratios and other data

Dec 31, Apr 2, July 2, Oct 1, Dec 31,
(unaudited, in millions €, except otherwise indicated) 2022 2023 2023 2023 2023
Gross profit as a percentage of net sales 51.5 % 50.6 % 51.3 % 51.9 % 51.4 %
Income from operations as a percentage of net sales 33.0 % 32.7 % 32.8 % 32.7 % 33.1 %
Net income as a percentage of net sales 28.2 % 29.0 % 28.1 % 28.4 % 28.3 %
Income taxes as a percentage of income before income taxes 16.8 % 13.6 % 17.7 % 15.7 % 16.1 %
Shareholders' equity as a percentage of total assets 24.3 % 27.8 % 28.7 % 32.0 % 33.7 %
Sales of lithography systems (in units) 1 106 100 113 112 124
Value of booked systems 2 6,316 3,752 4,500 2,602 9,186
Number of payroll employees in FTEs 36,112 37,704 38,866 39,850 40,310
Number of temporary employees in FTEs 2,974 2,816 2,676 2,416 2,107
  1. Lithography systems do not include metrology and inspection systems.

  2. Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets

Dec 31, Apr 2, July 2, Oct 1, Dec 31,
(unaudited, in millions €) 2022 2023 2023 2023 2023
ASSETS
Cash and cash equivalents 7,268.3 6,647.7 6,341.3 4,975.5 7,004.7
Short-term investments 107.7 4.8 5.1 5.4 5.4
Accounts receivable, net 5,323.8 3,454.7 3,963.6 3,910.5 4,334.1
Finance receivables, net 1,356.7 1,349.2 1,650.8 1,348.2 1,379.2
Current tax assets 33.4 253.6 595.8 854.3 1,001.2
Contract assets 131.9 236.4 191.9 266.5 240.1
Inventories, net 7,199.7 7,392.0 7,734.4 8,378.5 8,850.7
Other assets 1,643.4 1,722.4 1,915.3 1,916.8 1,578.5
Total current assets 23,064.9 21,060.8 22,398.2 21,655.7 24,393.9
Finance receivables, net 58.3 71.7 423.4 60.6
Deferred tax assets 1,672.8 1,667.4 1,679.1 1,827.4 1,872.3
Loan receivable 364.4 364.4 364.4 920.7 929.2
Other assets 739.8 1,012.8 996.3 859.2 651.8
Equity method investments 923.6 969.6 1,040.4 1,094.3 919.6
Goodwill 4,555.6 4,555.6 4,555.6 4,582.6 4,588.6
Other intangible assets, net 842.4 813.7 789.2 756.6 741.7
Property, plant and equipment, net 3,944.2 4,354.8 4,727.9 5,093.2 5,493.2
Right-of-use assets 192.7 290.2 305.7 300.4 306.6
Total non-current assets 13,235.5 14,086.8 14,530.3 15,857.8 15,563.6
Total assets 36,300.4 35,147.6 36,928.5 37,513.5 39,957.5
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities 17,983.6 16,948.1 16,754.3 16,309.5 16,274.8
Total current liabilities 17,983.6 16,948.1 16,754.3 16,309.5 16,274.8
Long-term debt 3,514.2 3,536.0 4,517.8 4,522.3 4,631.5
Deferred and other tax liabilities 267.0 293.0 372.8 380.4 372.2
Contract liabilities 5,269.9 4,147.4 4,205.3 3,826.0 4,825.5
Accrued and other liabilities 454.9 436.8 473.4 480.4 401.2
Total non-current liabilities 9,506.0 8,413.2 9,569.3 9,209.1 10,230.4
Total liabilities 27,489.6 25,361.3 26,323.6 25,518.6 26,505.2
Total shareholders' equity 8,810.8 9,786.3 10,604.9 11,994.9 13,452.3
Total liabilities and shareholders' equity 36,300.4 35,147.6 36,928.5 37,513.5 39,957.5

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows

Three months ended,
Dec 31, Apr 2, July 2, Oct 1, Dec 31,
(unaudited, in millions €) 2022 2023 2023 2023 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,816.5 1,955.8 1,941.7 1,893.4 2,048.1
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 183.2 170.3 181.2 176.2 212.1
Impairment and loss (gain) on disposal 13.7 3.2 3.9 20.4 10.0
Share-based compensation expense 21.0 18.3 33.4 41.5 41.6
Inventory reserves 71.3 81.7 90.6 102.3 210.7
Deferred tax expense (benefit) (89.0) 12.7 41.5 (138.9) (48.9)
Equity method investments 120.8 (46.8) (70.9) (53.8) 175.7
Changes in assets and liabilities 3,213.0 (1,461.6) (1,836.7) (913.0) 547.7
Net cash provided by (used in) operating activities 5,350.5 733.6 384.7 1,128.1 3,197.0
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (453.6) (532.0) (537.8) (501.8) (584.0)
Purchase of intangible assets (12.3) (7.4) (6.6) (8.3) (18.3)
Purchase of short-term investments (4.2) (18.2) (0.5) (3.9) (1.0)
Maturity of short-term investments 106.1 121.1 3.6 0.9
Loans issued and other investments (553.0) (8.5)
Acquisition of subsidiaries (net of cash acquired) (27.6) (6.0)
Net cash provided by (used in) investing activities (364.0) (436.5) (544.9) (1,091.0) (616.9)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid (541.1) (541.1) (666.1) (570.4) (570.8)
Purchase of treasury shares (335.0) (396.2) (492.6) (111.1)
Net proceeds from issuance of shares 18.9 22.7 25.1 25.7 25.9
Net proceeds from issuance of notes, net of issuance costs 997.8
Repayment of debt and finance lease obligations (0.8) (1.5) (0.7) (750.4) (0.2)
Net cash provided by (used in) financing activities (858.0) (916.1) (136.5) (1,406.2) (545.1)
Net cash flows 4,128.5 (619.0) (296.7) (1,369.1) 2,035.0
Effect of changes in exchange rates on cash (13.0) (1.6) (9.7) 3.3 (5.8)
Net increase (decrease) in cash and cash equivalents 4,115.5 (620.6) (306.4) (1,365.8) 2,029.2
Cash and cash equivalents at beginning of the period 3,152.8 7,268.3 6,647.7 6,341.3 4,975.5
Cash and cash equivalents at end of the period 7,268.3 6,647.7 6,341.3 4,975.5 7,004.7

Notes to the Summary US GAAP Consolidated Financial Statements

Basis of preparation

The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the accounting principles generally accepted in the United States of America ("US GAAP").

For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included within our 2022 Annual Report based on US GAAP, which is available on www.asml.com.

Forward Looking Statements

This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including trends in the semiconductor industry and end markets and business environment trends, including expected demand, utilization, inventory levels, backlog, bookings, expected recovery in the semiconductor industry and expected timing thereof, assumptions and expectations with respect to fast shipments, plans to increase capacity, outlook and expected financial results, including expected results for Q1 2024, including net sales, gross margin, R&D costs, SG&A costs, expected results for full year 2024, including expectations with respect to revenue and gross margin and estimated annualized effective tax rate, expectations with respect to sales by market segment and EUV, non-EUV and IBM sales and expected drivers thereof, and other full year 2024 expectations, expectations with respect to revenue growth in 2025 and expected drivers thereof, statements made at our 2022 Investor Day, including revenue and gross margin opportunity for 2025 and 2030, statements with respect to export control policy and regulations and expected impact on us, expectation to return significant amounts of cash to shareholders through growing dividends and share buybacks, including the amount of shares intended to be repurchased under the program and statements with respect to dividends, statements with respect to our ESG goals and strategy and other non-historical statements. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", "future", "progress", "goal", "opportunity", "potential" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, customer demand and semiconductor equipment industry capacity, worldwide demand for semiconductors and semiconductor manufacturing capacity, utilization and inventory levels, general trends and consumer confidence in the semiconductor industry, the impact of general economic conditions, including the impact of the current macroeconomic uncertainty on the semiconductor industry, the impact of inflation, interest rates, geopolitical developments, the impact of pandemics, performance of our systems, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, our production capacity and ability to adjust capacity to meet demand, supply chain capacity, constraints and logistics, timely availability of parts and components, raw materials, critical manufacturing equipment and qualified employees, and constraints on our ability to produce systems to meet demand, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push outs and restrictions on shipment of ordered systems under export controls, risks relating to the trade environment, import/export and national security regulations and orders and their impact on us, including the impact of changes in export regulations and the impact of such regulations on our ability to obtain necessary licenses and to sell our systems to certain customers, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, the number of shares repurchased under our share repurchase programs, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, our ability to meet ESG goals and execute our ESG strategy, other factors that may impact ASML's business or financial results, and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F for the year ended December 31, 2022 and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or to conform such statements to actual results or revised expectations, except as required by law.

Talk to a Data Expert

Have a question? We'll get back to you promptly.